Study of Breast Cancer Prevention by Letrozole in High Risk Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Placebo
Sponsor: Carol Fabian, MD
Collaborators: Novartis|National Cancer Institute (NCI)